- Home
- EYPT vs IMOS Comparison
EYPT vs IMOS Comparison
Compare EYPT & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- IMOS
- Stock Information
- Founded
- EYPT 1987
- IMOS 1997
- Country
- EYPT United States
- IMOS Taiwan
- Employees
- EYPT N/A
- IMOS N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- IMOS Semiconductors
- Sector
- EYPT Industrials
- IMOS Technology
- Exchange
- EYPT Nasdaq
- IMOS Nasdaq
- Market Cap
- EYPT 967.4M
- IMOS 980.5M
- IPO Year
- EYPT 2005
- IMOS N/A
- Fundamental
- Price
- EYPT $14.50
- IMOS $28.06
- Analyst Decision
- EYPT Strong Buy
- IMOS
- Analyst Count
- EYPT 5
- IMOS 0
- Target Price
- EYPT $29.60
- IMOS N/A
- AVG Volume (30 Days)
- EYPT 1.4M
- IMOS 23.8K
- Earning Date
- EYPT 11-05-2025
- IMOS 11-11-2025
- Dividend Yield
- EYPT N/A
- IMOS 2.30%
- EPS Growth
- EYPT N/A
- IMOS N/A
- EPS
- EYPT N/A
- IMOS 0.01
- Revenue
- EYPT $42,339,000.00
- IMOS $748,307,671.00
- Revenue This Year
- EYPT N/A
- IMOS $3.76
- Revenue Next Year
- EYPT N/A
- IMOS $5.93
- P/E Ratio
- EYPT N/A
- IMOS $131.29
- Revenue Growth
- EYPT N/A
- IMOS N/A
- 52 Week Low
- EYPT $3.91
- IMOS $12.78
- 52 Week High
- EYPT $14.91
- IMOS $30.98
- Technical
- Relative Strength Index (RSI)
- EYPT 65.45
- IMOS 62.57
- Support Level
- EYPT $13.43
- IMOS $27.20
- Resistance Level
- EYPT $14.67
- IMOS $30.00
- Average True Range (ATR)
- EYPT 0.91
- IMOS 1.02
- MACD
- EYPT 0.32
- IMOS 0.15
- Stochastic Oscillator
- EYPT 99.54
- IMOS 69.82
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.